These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 16156741

  • 1. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer's disease.
    Smith IF, Hitt B, Green KN, Oddo S, LaFerla FM.
    J Neurochem; 2005 Sep; 94(6):1711-8. PubMed ID: 16156741
    [Abstract] [Full Text] [Related]

  • 2. Increased intraneuronal resting [Ca2+] in adult Alzheimer's disease mice.
    Lopez JR, Lyckman A, Oddo S, Laferla FM, Querfurth HW, Shtifman A.
    J Neurochem; 2008 Apr; 105(1):262-71. PubMed ID: 18021291
    [Abstract] [Full Text] [Related]

  • 3. Enhanced ryanodine-mediated calcium release in mutant PS1-expressing Alzheimer's mouse models.
    Stutzmann GE, Smith I, Caccamo A, Oddo S, Parker I, Laferla F.
    Ann N Y Acad Sci; 2007 Feb; 1097():265-77. PubMed ID: 17413028
    [Abstract] [Full Text] [Related]

  • 4. Presenilin-1 deficiency impairs glutamate-evoked intracellular calcium responses in neurons.
    Yang Y, Cook DG.
    Neuroscience; 2004 Feb; 124(3):501-5. PubMed ID: 14980721
    [Abstract] [Full Text] [Related]

  • 5. Altered oxidant-mediated intraneuronal zinc mobilization in a triple transgenic mouse model of Alzheimer's disease.
    Sensi SL, Rapposelli IG, Frazzini V, Mascetra N.
    Exp Gerontol; 2008 May; 43(5):488-92. PubMed ID: 18068923
    [Abstract] [Full Text] [Related]

  • 6. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.
    Ferreiro E, Resende R, Costa R, Oliveira CR, Pereira CM.
    Neurobiol Dis; 2006 Sep; 23(3):669-78. PubMed ID: 16844381
    [Abstract] [Full Text] [Related]

  • 7. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T, Kosower NS, Katzav A, Chapman J, Barnoy S.
    Neurochem Int; 2007 Sep; 51(6-7):391-7. PubMed ID: 17513017
    [Abstract] [Full Text] [Related]

  • 8. High dietary consumption of trans fatty acids decreases brain docosahexaenoic acid but does not alter amyloid-beta and tau pathologies in the 3xTg-AD model of Alzheimer's disease.
    Phivilay A, Julien C, Tremblay C, Berthiaume L, Julien P, Giguère Y, Calon F.
    Neuroscience; 2009 Mar 03; 159(1):296-307. PubMed ID: 19135506
    [Abstract] [Full Text] [Related]

  • 9. Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice.
    Eckert A, Schindowski K, Leutner S, Luckhaus C, Touchet N, Czech C, Müller WE.
    Neurobiol Dis; 2001 Apr 03; 8(2):331-42. PubMed ID: 11300728
    [Abstract] [Full Text] [Related]

  • 10. Enhanced ryanodine receptor recruitment contributes to Ca2+ disruptions in young, adult, and aged Alzheimer's disease mice.
    Stutzmann GE, Smith I, Caccamo A, Oddo S, Laferla FM, Parker I.
    J Neurosci; 2006 May 10; 26(19):5180-9. PubMed ID: 16687509
    [Abstract] [Full Text] [Related]

  • 11. Disruption of endoplasmic reticulum calcium stores is involved in neuronal death induced by glycolysis inhibition in cultured hippocampal neurons.
    Hernández-Fonseca K, Massieu L.
    J Neurosci Res; 2005 Oct 15; 82(2):196-205. PubMed ID: 16175570
    [Abstract] [Full Text] [Related]

  • 12. Physical exercise protects against Alzheimer's disease in 3xTg-AD mice.
    García-Mesa Y, López-Ramos JC, Giménez-Llort L, Revilla S, Guerra R, Gruart A, Laferla FM, Cristòfol R, Delgado-García JM, Sanfeliu C.
    J Alzheimers Dis; 2011 Oct 15; 24(3):421-54. PubMed ID: 21297257
    [Abstract] [Full Text] [Related]

  • 13. Ryanodine receptor-mediated interference of neuronal cell differentiation by presenilin 2 mutation.
    Lee SM, Lee JW, Song YS, Hwang DY, Kim YK, Nam SY, Kim DJ, Yun YW, Yoon DY, Hong JT.
    J Neurosci Res; 2005 Nov 15; 82(4):542-50. PubMed ID: 16240390
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer's disease.
    Supnet C, Noonan C, Richard K, Bradley J, Mayne M.
    J Neurochem; 2010 Jan 15; 112(2):356-65. PubMed ID: 19903243
    [Abstract] [Full Text] [Related]

  • 15. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H, Sultana R, Keller JN, St Clair DK, Markesbery WR, Butterfield DA.
    J Neurochem; 2006 Mar 15; 96(5):1322-35. PubMed ID: 16478525
    [Abstract] [Full Text] [Related]

  • 16. Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels.
    Zatti G, Burgo A, Giacomello M, Barbiero L, Ghidoni R, Sinigaglia G, Florean C, Bagnoli S, Binetti G, Sorbi S, Pizzo P, Fasolato C.
    Cell Calcium; 2006 Jun 15; 39(6):539-50. PubMed ID: 16620965
    [Abstract] [Full Text] [Related]

  • 17. Presenilin 1 deficiency alters the activity of voltage-gated Ca2+ channels in cultured cortical neurons.
    Cook DG, Li X, Cherry SD, Cantrell AR.
    J Neurophysiol; 2005 Dec 15; 94(6):4421-9. PubMed ID: 16148264
    [Abstract] [Full Text] [Related]

  • 18. Presenilin 2 regulates the systolic function of heart by modulating Ca2+ signaling.
    Takeda T, Asahi M, Yamaguchi O, Hikoso S, Nakayama H, Kusakari Y, Kawai M, Hongo K, Higuchi Y, Kashiwase K, Watanabe T, Taniike M, Nakai A, Nishida K, Kurihara S, Donoviel DB, Bernstein A, Tomita T, Iwatsubo T, Hori M, Otsu K.
    FASEB J; 2005 Dec 15; 19(14):2069-71. PubMed ID: 16204356
    [Abstract] [Full Text] [Related]

  • 19. Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes.
    Sterniczuk R, Dyck RH, Laferla FM, Antle MC.
    Brain Res; 2010 Aug 12; 1348():139-48. PubMed ID: 20471965
    [Abstract] [Full Text] [Related]

  • 20. Aluminum modulates effects of beta amyloid(1-42) on neuronal calcium homeostasis and mitochondria functioning and is altered in a triple transgenic mouse model of Alzheimer's disease.
    Drago D, Cavaliere A, Mascetra N, Ciavardelli D, di Ilio C, Zatta P, Sensi SL.
    Rejuvenation Res; 2008 Oct 12; 11(5):861-71. PubMed ID: 18788899
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.